Artielle ImmunoTherapeutics' Convertible Note - VII Round

Artielle ImmunoTherapeutics raised a round of funding on September 10, 2010.

Artielle ImmunoTherapeutics is developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. Artielle's initial therapeutic focus is on neur…

Articles about Artielle ImmunoTherapeutics' Convertible Note - VII Round: